Literature DB >> 19720087

Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).

Alberto C S Costa1, Melissa R Stasko, Cecilia Schmidt, Muriel T Davisson.   

Abstract

The Ts65Dn mouse is the most studied and complete aneuploid model of Down syndrome (DS) widely available. As a model for human trisomy 21, these mice display many attractive features, including performance deficits in different behavioral tasks, alterations in synaptic plasticity and adult neurogenesis, motor dysfunction, and age-dependent cholinergic neurodegeneration. Currently, Ts65Dn mice are maintained on a genetic background that leads to blindness in about 25% of their offspring, because it segregates for the retinal degeneration 1 (Pde6b(rd1)) mutation of C3H/HeSnJ. This means that 25% of the mice have to be discarded in most experiments involving these animals, which is particularly problematic because the Ts65Dn stock has low reproductive performance. To circumvent this problem, we have bred the Ts65Dn extra chromosome many generations into a closely related genetic background that does not carry the Pde6b(rd1) mutation. Although the new genetic background is expected to be nearly identical to the original, differences in genetic background have the potential to alter mouse performance in certain behavioral tests. Therefore, we designed the present study primarily as a behavioral validation of Ts65Dn mice of the new background. We compared side-by-side their performance with that of Ts65Dn mice of the original background on the following set of assessments: (1) body length and weight; (2) 24-h locomotor activity; (3) the Morris water maze; (4) fear conditioning; and (5) grip strength. Except for very subtle differences on water maze performance, we found no significant differences between Ts65Dn mice on the two backgrounds in the measures assessed.

Entities:  

Mesh:

Year:  2009        PMID: 19720087      PMCID: PMC2783207          DOI: 10.1016/j.bbr.2009.08.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  48 in total

1.  Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome.

Authors:  Carmen Martínez-Cué; Carmela Baamonde; Marian Lumbreras; Jesús Paz; Muriel T Davisson; Cecilia Schmidt; Mara Dierssen; Jesús Flórez
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

2.  The effects of piracetam on cognitive performance in a mouse model of Down's syndrome.

Authors:  Timothy H Moran; George T Capone; Susan Knipp; Muriel T Davisson; Roger H Reeves; John D Gearhart
Journal:  Physiol Behav       Date:  2002-11

3.  Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins.

Authors:  Kelly T Dineley; Xuefeng Xia; Duy Bui; J David Sweatt; Hui Zheng
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

4.  Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.

Authors:  L A Hyde; D F Frisone; L S Crnic
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

5.  Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice.

Authors:  C A Turner; M F Presti; H A Newman; P Bugenhagen; L Crnic; M H Lewis
Journal:  Behav Genet       Date:  2001-07       Impact factor: 2.805

6.  Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.

Authors:  H Sago; E J Carlson; D J Smith; E M Rubin; L S Crnic; T T Huang; C J Epstein
Journal:  Pediatr Res       Date:  2000-11       Impact factor: 3.756

7.  Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Authors:  L L Baxter; T H Moran; J T Richtsmeier; J Troncoso; R H Reeves
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

8.  Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.

Authors:  Farahnaz Sananbenesi; André Fischer; Christina Schrick; Joachim Spiess; Jelena Radulovic
Journal:  Mol Cell Neurosci       Date:  2002-11       Impact factor: 4.314

9.  Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.

Authors:  Christopher L Hunter; Heather A Bimonte; Ann Charlotte E Granholm
Journal:  Behav Brain Res       Date:  2003-01-22       Impact factor: 3.332

Review 10.  Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.

Authors:  Mohammed Rachidi; Carmela Lopes
Journal:  Eur J Paediatr Neurol       Date:  2007-10-22       Impact factor: 3.140

View more
  37 in total

1.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Authors:  Laura G Reinholdt; Yueming Ding; Griffith J Gilbert; Griffith T Gilbert; Anne Czechanski; Jeffrey P Solzak; Randall J Roper; Mark T Johnson; Leah Rae Donahue; Cathleen Lutz; Muriel T Davisson
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 3.  Exosome release and cargo in Down syndrome.

Authors:  Eric D Hamlett; Angela LaRosa; Elliott J Mufson; Juan Fortea; Aurélie Ledreux; Ann-Charlotte Granholm
Journal:  Dev Neurobiol       Date:  2019-08-06       Impact factor: 3.964

Review 4.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine.

Authors:  Jonah J Scott-McKean; Alberto C S Costa
Journal:  Learn Mem       Date:  2011-11-18       Impact factor: 2.460

6.  Early impacts of modified food consistency on oromotor outcomes in mouse models of Down syndrome.

Authors:  Tiffany J Glass; Sara L Twadell; Luke C Valmadrid; Nadine P Connor
Journal:  Physiol Behav       Date:  2018-11-26

7.  Genetic dissection of the Down syndrome critical region.

Authors:  Xiaoling Jiang; Chunhong Liu; Tao Yu; Li Zhang; Kai Meng; Zhuo Xing; Pavel V Belichenko; Alexander M Kleschevnikov; Annie Pao; Jennifer Peresie; Sarah Wie; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

Review 8.  Influence of allelic differences in Down syndrome.

Authors:  Randall J Roper; Laura Hawley; Charles R Goodlett
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

9.  Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Authors:  Joseph W Goodliffe; Jose Luis Olmos-Serrano; Nadine M Aziz; Jeroen L A Pennings; Faycal Guedj; Diana W Bianchi; Tarik F Haydar
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

10.  Developmental localization of adhesion and scaffolding proteins at the cone synapse.

Authors:  John S Nuhn; Peter G Fuerst
Journal:  Gene Expr Patterns       Date:  2014-08-28       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.